Dr. Michelle White’s Thoughts on Gynecologic Cancer Awareness Month



By Dr. Michelle White, MD, FACOG

Vaginal and vulvar cancers are very rare. All women are at risk of these cancers. About 25% of women diagnosed with these cancers die from the disease. For this reason, it is important for every woman to learn about vaginal and vulvar cancers.

Each year, nearly 1,000 women are diagnosed with vaginal cancer and about 3,500 women with vulvar cancer in the U.S. These cancers typically occur in women in their fifties and sixties. Many vaginal and vulvar cancers are caused by human papillomavirus (HPV), a common virus that is passed from one person to another during sex. Other risk factors for these cancers include having cervical precancer or cancer, having a condition that makes it hard for your body to fight off health problems, and smoking. Some of these risks can be reduced by the HPV vaccine, limiting sexual partners, and not smoking.

Most vaginal cancers do not cause symptoms early on. When vaginal cancer does cause symptoms, they may include:

  • Vaginal discharge or bleeding that is not normal for you
  • A change in bathroom habits (blood in the stool or urine, more frequent trips to the bathroom, or constipation)
  • Abdomen or pelvic pain especially with urination or sex

Vulvar cancers often cause symptoms that may include:

  • Itching, burning or bleeding on the vulva
  • Color changes to the skin on the vulva
  • Sores, lumps, or ulcers on the vulva that do not go away
  • Pelvic pain especially with urination or sex

There are no tests that can find vaginal and vulvar cancers at this time. Your ANNUAL GYN visit is very important to look for signs of vulvar and vaginal cancer. We offer Women’s Wellness visits, HPV vaccinations to girls and women, and assistance with quitting smoking.

Dr. Sherley Samuels’ Thoughts on Gynecologic Cancer Awareness Month



By Dr. Sherley Samuels, MD, FACOG

Uterine cancer is the most common cancer of the female reproductive organs.

It is estimated that approximately 54,000 women will be diagnosed with uterine cancer during the year of 2015. Endometrial cancer, cancer of the inner uterine lining, is the most common type of uterine cancer. Cancer of the muscle layer of the uterus is a rarer form.

Women over the age of 55 are more likely than younger women to be diagnosed with endometrial cancer. Younger women, however, can be at increased risk in certain situations. Obesity increases a woman’s risk of endometrial cancer. Moreover, any ailment that prevents a woman from ovulating for long periods of time, such as polycystic ovarian syndrome (PCOS), can also increase the risk.

Endometrial cancer commonly presents with abnormal uterine bleeding. This includes bleeding that occurs after menopause has already taken place (postmenopausal bleeding), heavier bleeding with periods, or bleeding in between periods. Other symptoms include abnormal discharge, pelvic mass and/or pain, and weight loss. In order to make a diagnosis of endometrial cancer, a sample of the inner lining of the uterus must be examined by a pathologist. This tissue is obtained by an OB/GYN either via an endometrial biopsy in the office or a surgical procedure.

If uterine cancer is diagnosed prior to spreading outside of the uterus, the five-year survival rate is 95%. It is important to seek medical attention if you have any bleeding that is not typical of your menstrual cycle. Early detection can mean a more favorable prognosis!